These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14601152)

  • 1. Willingness to pay methods in health care: a sceptical view.
    Cookson R
    Health Econ; 2003 Nov; 12(11):891-4. PubMed ID: 14601152
    [No Abstract]   [Full Text] [Related]  

  • 2. Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.
    Gafni A
    Can J Nurs Res; 2001 Jun; 33(1):59-64. PubMed ID: 11928155
    [No Abstract]   [Full Text] [Related]  

  • 3. The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.
    Nocera S; Telser H; Bonato D
    Dev Health Econ Public Policy; 2003; 8():iii-xi, 1-116. PubMed ID: 15027158
    [No Abstract]   [Full Text] [Related]  

  • 4. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If the price is right: vagueness and values clarification in contingent valuation.
    Shiell A; Gold L
    Health Econ; 2003 Nov; 12(11):909-19. PubMed ID: 14601154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double discounting of QALYs.
    MacKeigan LD; Gafni A; O'Brien BJ
    Health Econ; 2003 Feb; 12(2):165-9. PubMed ID: 12563665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Ă˜sterdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods.
    Ryan M; Scott DA; Donaldson C
    J Health Econ; 2004 Mar; 23(2):237-58. PubMed ID: 15019754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness and ability to pay for health care: a selection of methods and issues.
    Russell S; Fox-Rushby J; Arhin D
    Health Policy Plan; 1995 Mar; 10(1):94-101. PubMed ID: 10141627
    [No Abstract]   [Full Text] [Related]  

  • 11. Willingness to pay and size of health benefit: an integrated model to test for 'sensitivity to scale'.
    Yeung RY; Smith RD; McGhee SM
    Health Econ; 2003 Sep; 12(9):791-6. PubMed ID: 12950096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory versus practice: a review of 'willingness-to-pay' in health and health care.
    Olsen JA; Smith RD
    Health Econ; 2001 Jan; 10(1):39-52. PubMed ID: 11180568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of a statistical life: theoretical and empirical evidence.
    Johansson PO
    Appl Health Econ Health Policy; 2002; 1(1):33-41. PubMed ID: 14618746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-social welfare functions: a reply to Hansen et al.
    Edlin R
    J Health Econ; 2004 Sep; 23(5):899-905. PubMed ID: 15353185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do ordering effects matter in willingness-to-pay studies of health care?
    Stewart JM; O'Shea E; Donaldson C; Shackley P
    J Health Econ; 2002 Jul; 21(4):585-99. PubMed ID: 12146592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
    Dolan P; Edlin R
    J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aiding priority setting in health care: is there a role for the contingent valuation method?
    Olsen JA
    Health Econ; 1997; 6(6):603-12. PubMed ID: 9466142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation.
    Smith RD
    Health Econ; 2001 Sep; 10(6):487-97. PubMed ID: 11550290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.
    Bala MV; Zarkin GA; Mauskopf JA
    Value Health; 2002; 5(4):338-46. PubMed ID: 12102696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to pay for what? A note on alternative definitions of health care program benefits for contingent valuation studies.
    Currie GR; Donaldson C; O'Bbrien BJ; Stoddart GL; Torrance GW; Drummond MF
    Med Decis Making; 2002; 22(6):493-7. PubMed ID: 12458979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.